Subacute Thyroiditis Medication
- Author: Mark R Allee, MD; Chief Editor: George T Griffing, MD more...
Glucocorticoids
Class Summary
These agents have anti-inflammatory properties and cause profound and varied metabolic effects. Corticosteroids modify the body's immune response to diverse stimuli.
Prednisone (Deltasone, Sterapred, Orasone)
Reduces inflammation and controls pain.
Beta-adrenergic Blocker
Class Summary
These agents inhibit chronotropic, inotropic, and vasodilatory response to beta-adrenergic stimulation.
Propranolol (Inderal)
Drug of choice in treating cardiac arrhythmias resulting from hyperthyroidism. Controls cardiac and psychomotor manifestations within minutes.
Atenolol (Tenormin)
Useful in treating cardiac arrhythmias resulting from hyperthyroidism. Controls cardiac and psychomotor manifestations within min.
Metoprolol (Lopressor, Toprol XL)
Selective beta1-adrenergic receptor blocker that decreases automaticity of contractions. Helps treat cardiac arrhythmias resulting from hyperthyroidism. Controls cardiac and psychomotor manifestations within min.
Analgesic Nonsteroidal Anti-inflammatory Drug
Class Summary
These agents have analgesic, anti-inflammatory, and antipyretic activities. Their mechanism of action is not known, but they may inhibit cyclooxygenase activity and prostaglandin synthesis. Other mechanisms may exist as well, such as inhibition of leukotriene synthesis, lysosomal enzyme release, lipoxygenase activity, neutrophil aggregation, and various cell-membrane functions.
Ibuprofen (Motrin, Ibuprin)
DOC for patients with mild to moderate pain. Inhibits inflammatory reactions and pain by decreasing prostaglandin synthesis.
Thyroid products
Class Summary
These agents are used for replacement therapy during hypothyroid phase when the patient becomes symptomatic.
Levothyroxine (Synthroid, Levoxyl, Levothroid)
DOC, rapidly inhibits the release of thyroid hormones via a direct effect on the thyroid gland and inhibits the synthesis of thyroid hormones. Iodide also appears to attenuate the cAMP-mediated effects of thyrotropin. In active form, influences growth and maturation of tissues. Involved in normal growth, metabolism, and development.
Ohsako N, Tamai H, Sudo T. Clinical characteristics of subacute thyroiditis classified according to human leukocyte antigen typing. J Clin Endocrinol Metab. Dec 1995;80(12):3653-6. [Medline].
Basaria S, Cooper DS. Amiodarone and the thyroid. Am J Med. Jul 2005;118(7):706-14.
Salvi A, Spandrio S, Tosoni M. Liver enzyme abnormalities in subacute thyroiditis. Recenti Prog Med. Nov 1990;81(11):686-8. [Medline].
Bianda T, Schmid C. De Quervain's subacute thyroiditis presenting as a painless solitary thyroid nodule. Postgrad Med J. Oct 1998;74(876):602-3. [Medline].
Bindra A, Braunstein GD. Thyroiditis. Am Fam Physician. May 15 2006;73(10):1769-76.
Chopra IJ, van Herle AJ, Korenman SG. Use of sodium ipodate in management of hyperthyroidism in subacute thyroiditis. J Clin Endocrinol Metab. Jul 1995;80(7):2178-80. [Medline].
Garcia Solano J, Gimenez Bascunana A, Sola Perez J. Fine-needle aspiration of subacute granulomatous thyroiditis (De Quervain's thyroiditis): a clinico-cytologic review of 36 cases. Diagn Cytopathol. Mar 1997;16(3):214-20. [Medline].
Hamburger JI. The various presentations of thyroiditis. Diagnostic considerations. Ann Intern Med. Feb 1986;104(2):219-24. [Medline].
Hay ID. Thyroiditis: a clinical update. Mayo Clin Proc. Dec 1985;60(12):836-43. [Medline].
Hiromatsu Y, Ishibashi M, Miyake I. Color Doppler ultrasonography in patients with subacute thyroiditis. Thyroid. Dec 1999;9(12):1189-93. [Medline].
Hiromatsu Y, Ishibashi M, Miyake I. Technetium-99m tetrofosmin imaging in patients with subacute thyroiditis. Eur J Nucl Med. Oct 1998;25(10):1448-52. [Medline].
Houghton DJ, Gray HW, MacKenzie K. The tender neck: thyroiditis or thyroid abscess?. Clin Endocrinol (Oxf). Apr 1998;48(4):521-4. [Medline].
Iitaka M, Momotani N, Ishii J. Incidence of subacute thyroiditis recurrences after a prolonged latency: 24-year survey. J Clin Endocrinol Metab. Feb 1996;81(2):466-9. [Medline].
Kannan CR, Seshadri KG. Thyrotoxicosis. Dis Mon. Sep 1997;43(9):601-77. [Medline].
Koga M, Hiromatsu Y, Jimi A. Immunohistochemical analysis of Bcl-2, Bax, and Bak expression in thyroid glands from patients with subacute thyroiditis. J Clin Endocrinol Metab. Jun 1999;84(6):2221-5. [Medline].
Lazarus JH. Silent thyroiditis and subacute thyroiditis. In: Braverman LE, Utiger RD, eds. The Thyroid: A fundamental and Clinical Text. Philadelphia, Pa:. JB Lippincott;1996:577.
Lio S, Pontecorvi A, Caruso M. Transitory subclinical and permanent hypothyroidism in the course of subacute thyroiditis (de Quervain). Acta Endocrinol (Copenh). May 1984;106(1):67-70. [Medline].
Mizukami Y, Michigishi T, Kawato M. Immunohistochemical and ultrastructural study of subacute thyroiditis, with special reference to multinucleated giant cells. Hum Pathol. Sep 1987;18(9):929-35. [Medline].
Ross DS. Syndromes of thyrotoxicosis with low radioactive iodine uptake. Endocrinol Metab Clin North Am. Mar 1998;27(1):169-85. [Medline].
Sakata S, Nagai K, Maekawa H. Serum ferritin concentration in subacute thyroiditis. Metabolism. Jul 1991;40(7):683-8. [Medline].
Shabb NS, Tawil A, Gergeos F. Multinucleated giant cells in fine-needle aspiration of thyroid nodules: their diagnostic significance. Diagn Cytopathol. Nov 1999;21(5):307-12. [Medline].
Watts NB, Sewell CW. Carcinomatous involvement of the thyroid presenting as subacute thyroiditis. Am J Med Sci. Aug 1988;296(2):126-8. [Medline].

